Icon 

$294.47
21
-$5.53-1.84% 今天

統計

當日最高
302.51
當日最低
294.42
52週最高
347.72
52週最低
221.2
成交量
348,664
平均成交量
609,088
市值
26.67B
市盈率
37.45
股息收益率
-
股息
-

即將到來

收益

23Oct預期
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一個
0
1.29
2.57
3.86
預期每股收益
3.856549
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 ICLR 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

分析師評級

360$平均價格目標
最高估價為 $383。
來自過去 6 個月內的 7 個評級。這不是投資建議。
買入
100%
持有
0%
賣出
0%

關於

Health Technology
Pharmaceuticals: Other
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.
Show more...
首席執行官
Stephen Cutler
員工
41100
國家
IE
ISIN
IE0005711209

上市公司